Generex wins new patents

The Canadian Intellectual Property Office has granted a patent for the process, formulation and use claims to a mixed micellar pharmaceutical formulation for buccal administration. The National Institute of Industrial Property of Argentina has granted the company a new patent for the process and formulation claims to a mixed liposome pharmaceutical formulation.

Rose Perri, COO of Generex, said: “We are pleased to continue to expand our patent portfolio, particularly in Canada, as we move towards the regulatory process for Generex Oral-lyn, once the Phase III pivotal study is completed in global sites.”